BioCentury | Aug 19, 2020
Product Development

Filgotinib setback a blow to building franchise around Gilead-Galapagos therapy

...III ISABELA trial; data for the ENPP2 inhibitor are expected in 1H21. Data for GLPG1205, a GPR84...
BioCentury | Jan 25, 2020
Emerging Company Profile

Aluda: targeting the fundamentals

...growth factor (CTGF) ENPP2 (ATX) - Autotaxin FGFR - Fibroblast growth factor receptor GPR84 - G protein-coupled receptor 84...
BioCentury | Jan 16, 2020
Company News

Galapagos to build fibrosis pipeline via extended Fibrocor partnership

...Positions Galapagos to Become Europe’s Next Big Biotech" ). Galapagos' next most advanced IPF therapy, GPR84...
...member. Targets: CFTR - Cystic fibrosis transmembrane conductance regulator; ENPP2 (ATX) - Autotaxin; GPR84 - G protein-coupled receptor 84 Sandi...
BioCentury | Jan 10, 2020
Emerging Company Profile

NorthSea: Engineering fatty acids for NASH

...known as Prometic Life Sciences Inc., has PBI 4547, a small molecule antagonist of the GPR84...
BioCentury | Feb 1, 2016
Clinical News

GLPG1205: Development discontinued

...indications. Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), Mechelen, Belgium Product: GLPG1205 Business: Autoimmune Molecular target: G protein-coupled receptor 84 (GPR84) Description: G protein-coupled receptor 84 (GPR84)...
BioCentury | Jan 27, 2016
Clinical News

Galapagos' GLPG1205 fails in Phase IIa UC trial

...baseline compared with placebo. Galapagos had planned to seek a partner for the G protein-coupled receptor 84 ( GPR84...
BioCentury | Jan 11, 2016
Strategy

Growing up Galapagos

...in the Benelux region. The company plans to seek a partner for GLPG1205 , a G protein-coupled receptor 84 (GPR84)...
...start Ph III 1H16); Ph II for Crohn's (data 1Q16) Gilead Sciences Inc. (NASDAQ:GILD) GLPG1205 G protein-coupled receptor 84 (GPR84)...
BioCentury | Jul 13, 2015
Clinical News

GLPG1205: Completed Phase II enrollment

...weeks. Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), Mechelen, Belgium Product: GLPG1205 Business: Autoimmune Molecular target: G protein-coupled receptor 84 (GPR84) Description: G protein-coupled receptor 84 (GPR84)...
BioCentury | Mar 23, 2015
Product Development

Galapagos' evolution inflection

...a "strategic portfolio prioritization decision." In January, Galapagos began a Phase II study of the G protein-coupled receptor 84 (GPR84)...
...RA data mid-April; Ph II Crohn's data mid-2015) AbbVie Inc. (NYSE:ABBV) GLPG1205 Selective inhibitor of G protein-coupled receptor 84 (GPR84)...
BioCentury | Mar 18, 2015
Company News

Galapagos, J&J terminate inflammation deal

...In December 2014, Janssen returned rights to GLPG1205 and all other compounds targeting G protein-coupled receptor 84 ( GPR84...
Items per page:
1 - 10 of 13